// App-Quantinova.ai

P569 : High Risk Pulmonary Embolism Complicated by Systemic Thrombosis Requiring Systemic Thrombolysis and Multiple Endovascular Procedures

Researchers

Presenter

  • S. Simeone

Principal Investigators

  • E. Nadler

Medical Centers

  • Department of Internal Medicine, University of Connecticut Health Center, Farmington, CT, United States

  • Department of Pulmonary and Critical Care Medicine, St. Francis Hospital and Medical Center, Hartford, CT, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Endocrine/metabolic Diseases (ME)

  • Blood/haematological Diseases

  • Ophthalmology (OP)

  • Cardiovascular (CVS)

  • Genetic Disorder

  • Pulmonary/Respiratory Diseases

Disease

  • Pulmonary embolism

  • Nephrolithiasis, calcium oxalate

  • Cardiac arrest

  • Hypertension

  • Venous thrombosis

  • Obesity

  • Cataract 6, multiple types

Biomarkers

  • EPH Receptor A2

Drug/Treatment

  • Heparin

  • Argatroban

  • Warfarin

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved